Study Assessing the Efficacy and Safety of Alpelisib + Nab-paclitaxel in Subjects With Advanced TNBC Who Carry Either a PIK3CA Mutation or Have PTEN Loss

Novartis Investigative Site, Ljubljana

Novartis Investigative Site, Lausanne

Novartis Investigative Site, Budapest

Novartis Investigative Site, Johannesburg

Novartis Investigative Site, Melbourne

Novartis Investigative Site, Plovdiv

Novartis Investigative Site, Nedlands

Novartis Investigative Site, Innsbruck

Novartis Investigative Site, Port Elizabeth

Novartis Investigative Site, Zagreb

Novartis Investigative Site, Taipei

Novartis Investigative Site, Taipei

Novartis Investigative Site, Trujillo

Novartis Investigative Site, Istanbul

Novartis Investigative Site, Istanbul

SCRI Oncology Partners, Nashville

Novartis Investigative Site, Saint-Herblain

Novartis Investigative Site, Essen

Novartis Investigative Site, Petaling Jaya

Novartis Investigative Site, Meldola

Novartis Investigative Site, Angers

Park Nicollet Institute, Saint Louis Park

Mayo Clinic Rochester, Rochester

Novartis Investigative Site, Kuala Lumpur

Novartis Investigative Site, Monterrey

Hematology and Oncology Clinic, Baton Rouge

Novartis Investigative Site, Napoli

Novartis Investigative Site, Bratislava

University of California LA, Los Angeles

Novartis Investigative Site, Saint-Cloud

Novartis Investigative Site, Villejuif

Novartis Investigative Site, Shenyang

Novartis Investigative Site, Shengyang

Novartis Investigative Site, Bogotá

Novartis Investigative Site, Dalian

Novartis Investigative Site, Moscow

Novartis Investigative Site, Moscow

Novartis Investigative Site, Changchun

Novartis Investigative Site, Arkhangelsk

Novartis Investigative Site, Saint Petersburg

Novartis Investigative Site, Shanghai

Novartis Investigative Site, Nanjing

Novartis Investigative Site, Hefei

Novartis Investigative Site, Tianjin

Novartis Investigative Site, Hangzhou

Novartis Investigative Site, Nanchang

Novartis Investigative Site, Mumbai

Novartis Investigative Site, Changsha

Novartis Investigative Site, Chelyabinsk

Novartis Investigative Site, Hyderabad

Novartis Investigative Site, Chengdu

Novartis Investigative Site, Tel Aviv

Novartis Investigative Site, Rosario

Novartis Investigative Site, CABA

Novartis Investigative Site, Leoben

Novartis Investigative Site, Barretos

Novartis Investigative Site, São Paulo

Novartis Investigative Site, São Paulo

Novartis Investigative Site, Shijiazhuang

Novartis Investigative Site, Dresden

Novartis Investigative Site, Leipzig

Novartis Investigative Site, Faridabad

Novartis Investigative Site, Vellore

Novartis Investigative Site, Roma

Novartis Investigative Site, Oslo

Novartis Investigative Site, Gdynia

Novartis Investigative Site, Opole

Novartis Investigative Site, Poznan

Novartis Investigative Site, Bratislava

Novartis Investigative Site, Košice

Novartis Investigative Site, Seoul

Novartis Investigative Site, Seoul

Novartis Investigative Site, Seoul

Novartis Investigative Site, Palma

Novartis Investigative Site, Badajoz

Novartis Investigative Site, Alicante

Novartis Investigative Site, Nottingham

Novartis Investigative Site, Oxford